{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T14:53:32Z","timestamp":1780325612985,"version":"3.54.1"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2018,10,18]],"date-time":"2018-10-18T00:00:00Z","timestamp":1539820800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1007\/s00210-018-1570-9","type":"journal-article","created":{"date-parts":[[2018,10,18]],"date-time":"2018-10-18T04:27:32Z","timestamp":1539836852000},"page":"1301-1318","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Craving espresso: the dialetics in classifying caffeine as an abuse drug"],"prefix":"10.1007","volume":"391","author":[{"given":"Max Kenedy Felix","family":"dos Santos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine C.","family":"Gavioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorena Santa","family":"Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"de Paula Soares-Rachetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4564-2288","authenticated-orcid":false,"given":"Bruno","family":"Lob\u00e3o-Soares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,10,18]]},"reference":[{"issue":"2","key":"1570_CR1","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/S0893-133X(02)00290-7","volume":"27","author":"E Acquas","year":"2002","unstructured":"Acquas E, Tanda G, Di CG (2002) Differential effects of caffeine on dopamine and acetylcholine transmission in brain areas of drug-naive and caffeine-pretreated rats. Neuropsychopharmacology. https:\/\/doi.org\/10.1016\/s0893-133x(02)00290-7","journal-title":"Neuropsychopharmacology"},{"issue":"Suppl 1","key":"1570_CR2","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1590\/S1516-44462005000500007","volume":"27","author":"F Al\u00f3e","year":"2005","unstructured":"Al\u00f3e F, de Azevedo AP, Hasan R (2005) Sleep-wake cycle mechanisms. Rev Bras Psiquiatr 27(Suppl 1):33\u201339","journal-title":"Rev Bras Psiquiatr"},{"key":"1570_CR3","first-page":"57","volume":"9","author":"LR Altimari","year":"2001","unstructured":"Altimari LR, Serpeloni E, Zucas SM, Okano H, Burini RC (2001) Cafe\u00edna: ergog\u00eanico nutricional no esporte Caffeine: nutritional ergogenic in Sports Origem e descri\u00e7\u00e3o. R Bras Ci\u00eane Mov 9:57\u201364","journal-title":"R Bras Ci\u00eane Mov"},{"key":"1570_CR4","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association (2013) Diagnostic and statistical manual of mental, 5th edn. American Psychiatric Publishing","DOI":"10.1176\/appi.books.9780890425596"},{"key":"1570_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1590\/S1677-04202006000100001","volume":"18","author":"H Ashihara","year":"2006","unstructured":"Ashihara H (2006) Metabolism of alkaloids in coffee plants. Braz J Plant Physiol 18:1\u20138. https:\/\/doi.org\/10.1590\/S1677-04202006000100001","journal-title":"Braz J Plant Physiol"},{"key":"1570_CR6","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.biosystems.2006.08.006","volume":"90","author":"AT Atanasov","year":"2007","unstructured":"Atanasov AT (2007) The linear allometric relationship between total metabolic energy per life span and body mass of mammals. Biosystems 90:224\u2013233. https:\/\/doi.org\/10.1016\/j.biosystems.2006.08.006","journal-title":"Biosystems"},{"key":"1570_CR7","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1111\/ejn.12114","volume":"37","author":"LK Baker","year":"2013","unstructured":"Baker LK, Mao D, Chi H, Govind AP, Vallejo YF, Iacoviello M, Herrera S, Cortright JJ, Green WN, McGehee DS, Vezina P (2013) Intermittent nicotine exposure upregulates nAChRs in VTA dopamine neurons and sensitises locomotor responding to the drug. Eur J Neurosci 37:1004\u20131011. https:\/\/doi.org\/10.1111\/ejn.12114","journal-title":"Eur J Neurosci"},{"key":"1570_CR8","first-page":"33","volume":"8","author":"LC Braga","year":"2000","unstructured":"Braga LC, Alves MP (2000) A cafe\u00edna como recurso ergog\u00eanico nos exerc\u00edcios de endurance. Rev Bras Ci\u00eanc Mov 8:33\u201337","journal-title":"Rev Bras Ci\u00eanc Mov"},{"key":"1570_CR9","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1590\/S0100-40422003000100023","volume":"26","author":"ECS Brenelli","year":"2003","unstructured":"Brenelli ECS (2003) A extra\u00e7\u00e3o de cafe\u00edna em bebidas estimulantes: uma nova abordagem para um experimento cl\u00e1ssico em qu\u00edmica org\u00e2nica. Quim Nova 26:136\u2013138. https:\/\/doi.org\/10.1590\/S0100-40422003000100023","journal-title":"Quim Nova"},{"key":"1570_CR10","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1007\/s11920-015-0611-z","volume":"17","author":"AJ Budney","year":"2015","unstructured":"Budney AJ, Lee DC, Juliano LM (2015) Evaluating the validity of caffeine use disorder. Curr Psychiatry Rep 17:74. https:\/\/doi.org\/10.1007\/s11920-015-0611-z","journal-title":"Curr Psychiatry Rep"},{"key":"1570_CR11","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/BF03190588","volume":"29","author":"GW Caldwell","year":"2004","unstructured":"Caldwell GW, Masucci JA, Yan Z, Hageman W (2004) Allometric scaling of pharmacokinetic parameters in drug discovery: can human CL, Vss and t1\/2 be predicted from in-vivo rat data? Eur J Drug Metab Pharmacokinet 29:133\u2013143","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"1570_CR12","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1038\/sj.npp.1300240","volume":"28","author":"O Cauli","year":"2003","unstructured":"Cauli O, Pinna A, Valentini V, Morelli M (2003) Subchronic caffeine exposure induces sensitization to caffeine and cross-sensitization to amphetamine ipsilateral turning behavior independent from dopamine release. Neuropsychopharmacology 28:1752\u20131759. https:\/\/doi.org\/10.1038\/sj.npp.1300240","journal-title":"Neuropsychopharmacology"},{"key":"1570_CR13","doi-asserted-by":"publisher","first-page":"127","DOI":"10.3233\/JAD-2010-1376","volume":"20","author":"X Chen","year":"2010","unstructured":"Chen X, Ghribi O, Geiger JD (2010) Caffeine protects against disruptions of the blood-brain barrier in animal models of Alzheimer\u2019s and Parkinson\u2019s diseases. J Alzheimers Dis 20:127\u2013141. https:\/\/doi.org\/10.3233\/JAD-2010-1376","journal-title":"J Alzheimers Dis"},{"key":"1570_CR14","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/38160","volume":"389","author":"LA Conlay","year":"1997","unstructured":"Conlay LA, Conant JA, deBros F, Wurtman R (1997) Caffeine alters plasma adenosine levels. Nature 389:136\u2013136. https:\/\/doi.org\/10.1038\/38160","journal-title":"Nature"},{"key":"1570_CR15","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/S0376-8716(98)00077-5","volume":"51","author":"JW Daly","year":"1998","unstructured":"Daly JW, Fredholm BB (1998) Caffeine\u2014an atypical drug of dependence. Drug Alcohol Depend 51:199\u2013206","journal-title":"Drug Alcohol Depend"},{"key":"1570_CR16","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1111\/j.1471-4159.2007.04754.x","volume":"103","author":"MA Luca De","year":"2007","unstructured":"De Luca MA, Bassareo V, Bauer A, Di Chiara G (2007) Caffeine and accumbens shell dopamine. J Neurochem 103:157\u2013163. https:\/\/doi.org\/10.1111\/j.1471-4159.2007.04754.x","journal-title":"J Neurochem"},{"key":"1570_CR17","doi-asserted-by":"publisher","first-page":"e10670","DOI":"10.1371\/journal.pone.0010670","volume":"5","author":"O Manzano De","year":"2010","unstructured":"De Manzano O, Cervenka S, Karabanov A, Farde L, Ull\u00e9n F (2010) Thinking outside a less intact box: thalamic dopamine D2 receptor densities are negatively related to psychometric creativity in healthy individuals. PLoS One 5:e10670. https:\/\/doi.org\/10.1371\/journal.pone.0010670","journal-title":"PLoS One"},{"key":"1570_CR18","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1016\/S0278-6915(02)00095-9","volume":"40","author":"PB Dews","year":"2002","unstructured":"Dews PB, O\u2019Brien CP, Bergman J (2002) Caffeine: behavioral effects of withdrawal and related issues. Food Chem Toxicol 40:1257\u20131261","journal-title":"Food Chem Toxicol"},{"key":"1570_CR19","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.brainres.2008.12.056","volume":"1258","author":"D Elmenhorst","year":"2009","unstructured":"Elmenhorst D, Basheer R, McCarley RW, Bauer A (2009) Sleep deprivation increases a(1) adenosine receptor density in the rat brain. Brain Res 1258:53\u201358. https:\/\/doi.org\/10.1016\/j.brainres.2008.12.056","journal-title":"Brain Res"},{"key":"1570_CR20","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/BF02245285","volume":"108","author":"SM Evans","year":"1992","unstructured":"Evans SM, Griffiths RR (1992) Caffeine tolerance and choice in humans. Psychopharmacology 108:51\u201359","journal-title":"Psychopharmacology"},{"key":"1570_CR21","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0022-3565(24)38135-2","volume":"289","author":"SM Evans","year":"1999","unstructured":"Evans SM, Griffiths RR (1999) Caffeine withdrawal: a parametric analysis of caffeine dosing conditions. J Pharmacol Exp Ther 289:285\u2013294","journal-title":"J Pharmacol Exp Ther"},{"key":"1570_CR22","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1046\/j.1460-9568.1998.00198.x","volume":"10","author":"S Fenu","year":"1998","unstructured":"Fenu S, Morelli M (1998) Motor stimulant effects of caffeine in 6-hydroxydopamine-lesioned rats are dependent on previous stimulation of dopamine receptors: a different role of D1 and D2 receptors. Eur J Neurosci 10:1878\u20131884","journal-title":"Eur J Neurosci"},{"key":"1570_CR23","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1007\/s00213-016-4212-2","volume":"233","author":"S Ferr\u00e9","year":"2016","unstructured":"Ferr\u00e9 S (2016) Mechanisms of the psychostimulant effects of caffeine: implications for substance use disorders. Psychopharmacology 233:1963\u20131979. https:\/\/doi.org\/10.1007\/s00213-016-4212-2","journal-title":"Psychopharmacology"},{"key":"1570_CR24","doi-asserted-by":"publisher","first-page":"S35","DOI":"10.3233\/JAD-2010-1400","volume":"20","author":"S Ferr\u00e9","year":"2010","unstructured":"Ferr\u00e9 S (2010) Role of the central ascending neurotransmitter systems in the psychostimulant effects of caffeine. J Alzheimers Dis 20:S35\u2013S49. https:\/\/doi.org\/10.3233\/JAD-2010-1400","journal-title":"J Alzheimers Dis"},{"key":"1570_CR25","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/J.NEUROPHARM.2015.05.028","volume":"104","author":"S Ferr\u00e9","year":"2016","unstructured":"Ferr\u00e9 S, Bonaventura J, Tomasi D, Navarro G, Moreno E, Cort\u00e9s A, Llu\u00eds C, Casad\u00f3 V, Volkow ND (2016) Allosteric mechanisms within the adenosine A2A\u2013dopamine D2 receptor heterotetramer. Neuropharmacology 104:154\u2013160. https:\/\/doi.org\/10.1016\/J.NEUROPHARM.2015.05.028","journal-title":"Neuropharmacology"},{"key":"1570_CR26","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.tins.2007.07.001","volume":"30","author":"S Ferr\u00e9","year":"2007","unstructured":"Ferr\u00e9 S, Ciruela F, Woods AS, Lluis C, Franco R (2007) Functional relevance of neurotransmitter receptor heteromers in the central nervous system. Trends Neurosci 30:440\u2013446. https:\/\/doi.org\/10.1016\/j.tins.2007.07.001","journal-title":"Trends Neurosci"},{"key":"1570_CR27","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/0014-2999(91)90064-W","volume":"192","author":"S Ferr\u00e9","year":"1991","unstructured":"Ferr\u00e9 S, Herrera-Marschitz M, Grabowska-And\u00e9n M, Ungerstedt U, Casas M, And\u00e9n N-E (1991a) Postsynaptic dopamine\/adenosine interaction: I. Adenosine analogues inhibit dopamine D2-mediated behaviour in short-term reserpinized mice. Eur J Pharmacol 192:25\u201330. https:\/\/doi.org\/10.1016\/0014-2999(91)90064-W","journal-title":"Eur J Pharmacol"},{"key":"1570_CR28","doi-asserted-by":"publisher","first-page":"7238","DOI":"10.1073\/pnas.88.16.7238","volume":"88","author":"S Ferr\u00e9","year":"1991","unstructured":"Ferr\u00e9 S, von Euler G, Johansson B, Fredholm BB, Fuxe K (1991b) Stimulation of high-affinity adenosine A2 receptors decreases the affinity of dopamine D2 receptors in rat striatal membranes. Proc Natl Acad Sci U S A 88:7238\u20137241","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1570_CR29","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0031-6997(24)01396-6","volume":"51","author":"BB Fredholm","year":"1999","unstructured":"Fredholm BB, B\u00e4ttig K, Holm\u00e9n J, Nehlig A, Zvartau EE (1999) Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol Rev 51:83\u2013133","journal-title":"Pharmacol Rev"},{"key":"1570_CR30","first-page":"48","volume":"52","author":"K Fuxe","year":"1974","unstructured":"Fuxe K, Ungerstedt U (1974) Action of caffeine and theophyllamine on supersensitive dopamine receptors: considerable enhancement of receptor response to treatment with DOPA and dopamine receptor agonists. Med Biol 52:48\u201354","journal-title":"Med Biol"},{"key":"1570_CR31","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/npp.2008.116","volume":"34","author":"N Ginovart","year":"2009","unstructured":"Ginovart N, A a W, Hussey D, Houle S, Kapur S (2009) D2-receptor upregulation is dependent upon temporal course of D2-occupancy: a longitudinal [11C]-raclopride PET study in cats. Neuropsychopharmacology 34:662\u2013671. https:\/\/doi.org\/10.1038\/npp.2008.116","journal-title":"Neuropsychopharmacology"},{"key":"1570_CR32","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1124\/mol.52.3.524","volume":"52","author":"M Gopalakrishnan","year":"1997","unstructured":"Gopalakrishnan M, Molinari EJ, Sullivan JP (1997) Regulation of human alpha4beta2 neuronal nicotinic acetylcholine receptors by cholinergic channel ligands and second messenger pathways. Mol Pharmacol 52:524\u2013534","journal-title":"Mol Pharmacol"},{"key":"1570_CR33","doi-asserted-by":"crossref","unstructured":"Griffiths R, Evans S, Heishman S, Preston K, Sannerud C, Wolf B, Woodson P (1990) Low-dose caffeine physical dependence in humans. J Pharmacol Exp Ther 255","DOI":"10.1016\/S0022-3565(25)23150-0"},{"key":"1570_CR34","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/B978-0-12-004702-4.50010-2","volume":"2","author":"RR Griffiths","year":"1979","unstructured":"Griffiths RR, Brady JV, Bradford LD (1979) Predicting the abuse liability of drugs with animal drug self-administration procedures: psychomotor stimulants and hallucinogens. Adv Behav Pharmacol 2:163\u2013208. https:\/\/doi.org\/10.1016\/B978-0-12-004702-4.50010-2","journal-title":"Adv Behav Pharmacol"},{"key":"1570_CR35","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/0091-3057(91)90448-B","volume":"246","author":"RR Griffiths","year":"1988","unstructured":"Griffiths RR, Woodson PP (1988a) Reinforcing effects of caffeine in humans. J Pharmacol Exp Ther 246:21\u201329. https:\/\/doi.org\/10.1016\/0091-3057(91)90448-B","journal-title":"J Pharmacol Exp Ther"},{"key":"1570_CR36","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/BF00212836","volume":"94","author":"RR Griffiths","year":"1988","unstructured":"Griffiths RR, Woodson PP (1988b) Caffeine physical dependence: a review of human and laboratory animal studies. Psychopharmacology 94:437\u2013451","journal-title":"Psychopharmacology"},{"key":"1570_CR37","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/0091-3057(88)90180-3","volume":"29","author":"RR Griffiths","year":"1988","unstructured":"Griffiths RR, Woodson PP (1988c) Reinforcing properties of caffeine: studies in humans and laboratory animals. Pharmacol Biochem Behav 29:419\u2013427. https:\/\/doi.org\/10.1016\/0091-3057(88)90180-3","journal-title":"Pharmacol Biochem Behav"},{"key":"1570_CR38","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1037\/a0027246","volume":"26","author":"LM Juliano","year":"2012","unstructured":"Juliano LM, Evatt DP, Richards BD, Griffiths RR (2012) Characterization of individuals seeking treatment for caffeine dependence. Psychol Addict Behav 26:948\u2013954. https:\/\/doi.org\/10.1037\/a0027246","journal-title":"Psychol Addict Behav"},{"key":"1570_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00213-004-2000-x","volume":"176","author":"LM Juliano","year":"2004","unstructured":"Juliano LM, Griffiths RR (2004) A critical review of caffeine withdrawal: empirical validation of symptoms and signs, incidence, severity, and associated features. Psychopharmacology 176:1\u201329","journal-title":"Psychopharmacology"},{"key":"1570_CR40","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1097\/00001756-200402090-00014","volume":"15","author":"V Kaasinen","year":"2004","unstructured":"Kaasinen V, Aalto S, N\u00e5gren K, Rinne JO (2004) Dopaminergic effects of caffeine in the human striatum and thalamus. Neuroreport 15:281\u2013285. https:\/\/doi.org\/10.1097\/00001756-200402090-00014","journal-title":"Neuroreport"},{"key":"1570_CR41","doi-asserted-by":"publisher","first-page":"S71","DOI":"10.3233\/JAD-2010-1417","volume":"20","author":"F Koppelstaetter","year":"2010","unstructured":"Koppelstaetter F, Poeppel TD, Siedentopf CM, Ischebeck A, Kolbitsch C, Mottaghy FM, Felber SR, Jaschke WR, Krause BJ (2010) Caffeine and cognition in functional magnetic resonance imaging. J Alzheimers Dis 20:S71\u2013S84","journal-title":"J Alzheimers Dis"},{"key":"1570_CR42","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.neuroimage.2007.08.037","volume":"39","author":"F Koppelstaetter","year":"2008","unstructured":"Koppelstaetter F, Poeppel TD, Siedentopf CM, Ischebeck A, Verius M, Haala I, Mottaghy FM, Rhomberg P, Golaszewski S, Gotwald T, Lorenz IH, Kolbitsch C, Felber S, Krause BJ (2008) Does caffeine modulate verbal working memory processes? An fMRI study. Neuroimage 39:492\u2013499. https:\/\/doi.org\/10.1016\/j.neuroimage.2007.08.037","journal-title":"Neuroimage"},{"key":"1570_CR43","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/S0278-6915(02)00093-5","volume":"40","author":"HG Mandel","year":"2002","unstructured":"Mandel HG (2002) Update on caffeine consumption, disposition and action. Food Chem Toxicol 40:1231\u20131234","journal-title":"Food Chem Toxicol"},{"key":"1570_CR44","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.ejphar.2011.03.052","volume":"660","author":"MT Marin","year":"2011","unstructured":"Marin MT, Zancheta R, Paro AH, Possi APM, Cruz FC, Planeta CS (2011) Comparison of caffeine-induced locomotor activity between adolescent and adult rats. Eur J Pharmacol 660:363\u2013367. https:\/\/doi.org\/10.1016\/j.ejphar.2011.03.052","journal-title":"Eur J Pharmacol"},{"key":"1570_CR45","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1089\/jcr.2013.0016","volume":"3","author":"SE Meredith","year":"2013","unstructured":"Meredith SE, Juliano LM, Hughes JR, Griffiths RR (2013) Caffeine use disorder: a comprehensive review and research agenda. J Caffeine Res 3:114\u2013130. https:\/\/doi.org\/10.1089\/jcr.2013.0016","journal-title":"J Caffeine Res"},{"key":"1570_CR46","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/S0149-7634(98)00050-5","volume":"23","author":"A Nehlig","year":"1999","unstructured":"Nehlig A (1999) Are we dependent upon coffee and caffeine? A review on human and animal data. Neurosci Biobehav Rev 23:563\u2013576","journal-title":"Neurosci Biobehav Rev"},{"key":"1570_CR47","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/S0006-8993(99)02480-4","volume":"858","author":"A Nehlig","year":"2000","unstructured":"Nehlig A, Boyet S (2000) Dose-response study of caffeine effects on cerebral functional activity with a specific focus on dependence. Brain Res 858:71\u201377. https:\/\/doi.org\/10.1016\/S0006-8993(99)02480-4","journal-title":"Brain Res"},{"key":"1570_CR48","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/0165-0173(92)90012-B","volume":"17","author":"A Nehlig","year":"1992","unstructured":"Nehlig A, Daval JL, Debry G (1992) Caffeine and the central nervous system: mechanisms of action, biochemical, metabolic and psychostimulant effects. Brain Res Brain Res Rev 17:139\u2013170","journal-title":"Brain Res Brain Res Rev"},{"key":"1570_CR49","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1590\/S0001-37652002000300007","volume":"74","author":"R Paes-De-Carvalho","year":"2002","unstructured":"Paes-De-Carvalho R (2002) Adenosine as a signaling molecule in the retina: biochemical and developmental aspects. An Acad Bras Cienc 74:437\u2013451. https:\/\/doi.org\/10.1590\/S0001-37652002000300007","journal-title":"An Acad Bras Cienc"},{"key":"1570_CR50","doi-asserted-by":"publisher","first-page":"225","DOI":"10.20882\/adicciones.303","volume":"19","author":"R Pardo Lozano","year":"2007","unstructured":"Pardo Lozano R, Alvarez Garc\u00eda Y, Barral Tafalla D, Farr\u00e9 Albaladejo M (2007) Caffeine: a nutrient, a drug or a drug of abuse. Adicciones 19:225\u2013238","journal-title":"Adicciones"},{"key":"1570_CR51","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.mri.2013.12.018","volume":"32","author":"C-A Park","year":"2014","unstructured":"Park C-A, Kang C-K, Son Y-D, Choi E-J, Kim S-H, Oh S-T, Kim Y-B, Park C-W, Cho Z-H (2014) The effects of caffeine ingestion on cortical areas: functional imaging study. Magn Reson Imaging 32:366\u2013371. https:\/\/doi.org\/10.1016\/j.mri.2013.12.018","journal-title":"Magn Reson Imaging"},{"key":"1570_CR52","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0026-895X(25)09730-5","volume":"46","author":"X Peng","year":"1994","unstructured":"Peng X, Gerzanich V, Anand R, Whiting PJ, Lindstrom J (1994) Nicotine-induced increase in neuronal nicotinic receptors results from a decrease in the rate of receptor turnover. Mol Pharmacol 46:523\u2013530","journal-title":"Mol Pharmacol"},{"key":"1570_CR53","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1159\/000315496","volume":"86","author":"AE Pollack","year":"2010","unstructured":"Pollack AE, Dimitrov KD, Drake JD (2010) Prior treatment (priming) with caffeine sensitizes D2-dopamine-mediated contralateral rotational behavior in 6-hydroxydopamine-lesioned rats. Pharmacology 86:73\u201378. https:\/\/doi.org\/10.1159\/000315496","journal-title":"Pharmacology"},{"key":"1570_CR54","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1046\/j.1471-4159.2003.02245.x","volume":"88","author":"D Quarta","year":"2004","unstructured":"Quarta D, Ferr\u00e9 S, Solinas M, You ZB, Hockemeyer J, Popoli P, Goldberg SR (2004) Opposite modulatory roles for adenosine A1 and A2A receptors on glutamate and dopamine release in the shell of the nucleus accumbens. Effects of chronic caffeine exposure. J Neurochem 88:1151\u20131158. https:\/\/doi.org\/10.1046\/j.1471-4159.2003.02245.x","journal-title":"J Neurochem"},{"key":"1570_CR55","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.pbb.2011.04.001","volume":"99","author":"DE Rhoads","year":"2011","unstructured":"Rhoads DE, Huggler AL, Rhoads LJ (2011) Acute and adaptive motor responses to caffeine in adolescent and adult rats. Pharmacol Biochem Behav 99:81\u201386. https:\/\/doi.org\/10.1016\/j.pbb.2011.04.001","journal-title":"Pharmacol Biochem Behav"},{"key":"1570_CR56","unstructured":"Ribeiro JA, Sebastio AM (2010) Caffeine and adenosine. J Alzheimer\u2019s Dis S3\u201315"},{"key":"1570_CR57","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/BF02245818","volume":"120","author":"PJ Rogers","year":"1995","unstructured":"Rogers PJ, Elliman NA, Richardson NJ (1995) Overnight caffeine abstinence and negative reinforcement of preference for caffeine-containing drinks. Psychopharmacology 120:457\u2013462","journal-title":"Psychopharmacology"},{"key":"1570_CR58","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1007\/s002130050246","volume":"130","author":"KJ Schuh","year":"1997","unstructured":"Schuh KJ, Griffiths RR (1997) Caffeine reinforcement: the role of withdrawal. Psychopharmacology 130:320\u2013326","journal-title":"Psychopharmacology"},{"key":"1570_CR59","doi-asserted-by":"publisher","first-page":"6321","DOI":"10.1523\/JNEUROSCI.22-15-06321.2002","volume":"22","author":"M Solinas","year":"2002","unstructured":"Solinas M, Ferr\u00e9 S, You Z-B, Karcz-Kubicha M, Popoli P, Goldberg SR (2002) Caffeine induces dopamine and glutamate release in the shell of the nucleus accumbens. J Neurosci 22:6321\u20136324","journal-title":"J Neurosci"},{"key":"1570_CR60","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/0006-3223(88)90064-9","volume":"23","author":"GR Stoner","year":"1988","unstructured":"Stoner GR, Skirboll LR, Werkman S, Hommer DW (1988) Preferential effects of caffeine on limbic and cortical dopamine systems. Biol Psychiatry 23:761\u2013768. https:\/\/doi.org\/10.1016\/0006-3223(88)90064-9","journal-title":"Biol Psychiatry"},{"key":"1570_CR61","first-page":"437","volume":"88","author":"E Strain","year":"1995","unstructured":"Strain E, Griffiths R (1995) Caffeine dependence: fact or fiction? J R Soc Med 88:437\u2013440","journal-title":"J R Soc Med"},{"key":"1570_CR62","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1089\/jcr.2011.0029","volume":"1","author":"CLW Striley","year":"2011","unstructured":"Striley CLW, Griffiths RR, Cottler LB (2011) Evaluating dependence criteria for caffeine. J Caffeine Res 1:219\u2013225. https:\/\/doi.org\/10.1089\/jcr.2011.0029","journal-title":"J Caffeine Res"},{"key":"1570_CR63","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/0735-6757(87)90416-5","volume":"5","author":"KA Stringer","year":"1987","unstructured":"Stringer KA, Watson WA (1987) Caffeine withdrawal symptoms. Am J Emerg Med 5:469. https:\/\/doi.org\/10.1016\/0735-6757(87)90416-5","journal-title":"Am J Emerg Med"},{"key":"1570_CR64","doi-asserted-by":"publisher","first-page":"111","DOI":"10.2144\/000113719","volume":"51","author":"P Trifilieff","year":"2011","unstructured":"Trifilieff P, Rives M-L, Urizar E, Piskorowski R, Vishwasrao H, Castrillon J, Schmauss C, Sl\u00e4ttman M, Gullberg M, Javitch J (2011) Detection of antigen interactions ex vivo by proximity ligation assay: endogenous dopamine D2-adenosine A2A receptor complexes in the striatum. Biotechniques 51:111\u2013118. https:\/\/doi.org\/10.2144\/000113719","journal-title":"Biotechniques"},{"key":"1570_CR65","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/0091-3057(77)90116-2","volume":"6","author":"MV Vitiello","year":"1977","unstructured":"Vitiello MV, Woods SC (1977) Evidence for withdrawal from caffeine by rats. Pharmacol Biochem Behav 6:553\u2013555. https:\/\/doi.org\/10.1016\/0091-3057(77)90116-2","journal-title":"Pharmacol Biochem Behav"},{"key":"1570_CR66","doi-asserted-by":"publisher","first-page":"e549","DOI":"10.1038\/tp.2015.46","volume":"5","author":"ND Volkow","year":"2015","unstructured":"Volkow ND, Wang G-J, Logan J, Alexoff D, Fowler JS, Thanos PK, Wong C, Casado V, Ferre S, Tomasi D (2015) Caffeine increases striatal dopamine D2\/D3 receptor availability in the human brain. Transl Psychiatry 5:e549. https:\/\/doi.org\/10.1038\/tp.2015.46","journal-title":"Transl Psychiatry"},{"key":"1570_CR67","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1037\/0033-295X.94.4.469","volume":"94","author":"RA Wise","year":"1987","unstructured":"Wise RA, Bozarth MA (1987) A psychomotor stimulant theory of addiction. Psychol Rev 94:469\u2013492. https:\/\/doi.org\/10.1037\/0033-295X.94.4.469","journal-title":"Psychol Rev"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00210-018-1570-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-018-1570-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-018-1570-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T20:33:46Z","timestamp":1775248426000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00210-018-1570-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,18]]},"references-count":67,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1570"],"URL":"https:\/\/doi.org\/10.1007\/s00210-018-1570-9","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,18]]},"assertion":[{"value":"26 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}